The test also maps variants in the FTO and MC4R genes that influence appetite regulation and body composition response
Thyroid Dysfunction: A sluggish thyroid that slows down calorie burning
After weighting, the use of GLP-1 receptor agonists was not associated with an increased risk of suicidality compared with DPP-4 inhibitors (weighted incidence rate 3.9 (95% CI 3.5 to 4.4) v 3.7 (3.6 to 3.9) per 1000 person years, respectively
Dai W-C, Zhang H-W, Yu J, Xu H-J, Chen H, Luo S-P, et al
But every injection afterwards no side effect
While a guest on the "Club Shay Shay" podcast, Iglesias explained why he ditched the GLP-1 that seemed to be working: "The problem with Ozempic is you're going to lose more muscle than fat." A 2024 review in Diabetes, Obesity, and Metabolism supports his assertion to an extent, stating that studies show GLP-1 use may cause the loss of up to 60% of a person's total lean muscle